We are pleased to welcome Dr. Srinivas (Sri) Tantravahi to the faculty in the Division of Hematology and Hematologic Malignancies as a Clinical Instructor. Sri completed his medical school education in the Guntur Medical College in India and subsequently completed a residency in Internal Medicine at the Sheffield Teaching Hospitals in the United Kingdom and obtained membership in the Royal College of Physicians. He scored highly on the USMLE and distinguished himself in a second residency in Internal Medicine at the University of Utah, which he completed in 2011. He then accepted a Fellowship position in Hematology and Oncology at the University of Utah. During this time he engaged in bench research in the laboratory of Dr. Mike Deininger and Dr. Thomas O’Hare. The focus of his research has been on the mechanisms of resistance of CML patients to tyrosine kinase inhibitor therapy. Sri and his colleagues demonstrated that TKI resistance arises from both mutations in the BCR-ABL1 kinase and other cellular pathways. Through his research on chronic myeloid leukemia, he successfully leveraged a competitive Research Training Award from the American Society of Hematology to extend his research work. During his residency and fellowship Sri published 14 manuscripts in peer-reviewed journals. His clinical work at Huntsman Cancer Institute will include chronic myeloid malignancies, multiple myeloma and bone marrow transplantation. We welcome Dr. Tantravahi to our faculty.